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Mercè Correa 1,2*, Noemí SanMiguel 1, Laura López-Cruz 1†, Carla Carratalá-Ros 1,
Régulo Olivares-García 1 and John D. Salamone 2
1 Àrea de Psicobiologia, Campus de Riu Sec, Universitat Jaume I, Castelló, Spain, 2 Behavioral Neuroscience Division,
University of Connecticut, Storrs, CT, United States
Caffeine is a methylxanthine consumed in different contexts to potentiate alertness and
reduce fatigue. However, caffeine can induce anxiety at high doses. Caffeine is also
a minor psychostimulant that seems to act as an appetite suppressant, but there are
also reports indicating that it could stimulate appetite. Dopamine also is involved in food
motivation and in behavioral activation. In the present series of experiments, we evaluated
the effects of acute administration of caffeine on food consumption under different access
conditions. CD1 male adult mice had access to highly palatable food (50% sucrose)
in a restricted but habitual context, under continuous or intermittent access as well as
under anxiogenic, or effortful conditions. Caffeine (2.5–20.0 mg/kg) increased intake at
the highest dose under familiar continuous and intermittent access. However, this high
dose reduced food intake in the dark-light paradigm. In contrast, a dopamine-depleting
agent, tetrabenazine (TBZ; 1.0–8.0 mg/kg) did not affect food intake in any of those
experimental conditions. In the T-maze-barrier task that evaluates seeking and taking
of food under effortful conditions, caffeine (10.0 mg/kg) decreased latency to reach the
food, but did not affect selection of the high-food density arm that required more effort,
or the total amount of food consumed. In contrast, TBZ (4.0 mg/kg) reduced selection
of the high food density arm with the barrier, thus affecting amount of food consumed.
Interestingly, a small dose of caffeine (5.0mg/kg) was able to reverse the anergia-inducing
effects produced by TBZ in the T-maze. These results suggest that caffeine can potentiate
or suppress food consumption depending on the context. Moreover, caffeine did not
change appetite, and did not impair orientation toward food under effortful conditions,
but it rather helped to achieve the goal by improving speed and by reversing performance
to normal levels when fatigue was induced by dopamine depletion.
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INTRODUCTION
Caffeine is the psychostimulant substance most widely consumed
in the world, and it is found in several types of food and
beverages (1). Psychostimulants are characterized by stimulation
of locomotion and feelings of invigoration and increase in
perceived energy, although at high doses they can induce
stereotypies and anxiety (2–5). This category of drugs is known
for its anorectic effects, and in fact caffeine is a common
constituent in over-the-counter weight-loss supplements (6).
However, caffeine in humans does not seem to have a consistent
pattern of effects on appetite and energy intake. While some
studies report that it exerts a slight anorectic effect (7), others do
not report significant changes (8, 9).
In animal studies, the literature shows also a complex pattern
of results. In non-deprived mice, a recent study demonstrated
that acute administration of caffeine (6.0–24.0 mg/kg) increases
intake of standard free chow, and that animals are not more
activated or anxious (10). In different types of operant conditions
imposed on food restricted rats, acute doses of caffeine produce
dose dependent effects; doses of 40.0 mg/kg or higher reduced
lever pressing for different types of food (11, 12), and doses up
to 25.0 mg/kg increased lever pressing independently if there was
no net increase on food access (12–14).
Nucleus accumbens (Nacb) dopamine (DA) has been
implicated in some features of food motivation (15–18). Caffeine
does not clearly induce Nacb DA release (19, 20). However,
it is a non-selective adenosine receptor antagonist, and these
receptors have a functional interaction with DA receptors in
striatum. Adenosine receptors are co-localized with DA receptors
converging into the same intracellular cascade in an opposite
way; while A1 receptors are co-localized with D1 receptors, A2A
receptors are co-localized with D2 receptors in different groups
of striatal neurons (21–23). Thus, antagonism of adenosine
receptors leads to the opposite effect to DA antagonism. Several
previous studies have focused on the functional interaction
between adenosine and DA receptors in studies of effort-
related decision-making processes that allow access to different
quantities or types of food in food restricted animals (15, 24–
26). For example, in a T-maze procedure in which mice have
to jump a barrier to get access to a relatively large quantity of
food, co-administration of theophylline, another methylxantine
that acts as a non-selective adenosine antagonist, reversed the
anergia inducing effects of a DAD2 receptor antagonist, restoring
normal levels of effort that lead to more food (26).
In the present studies, we wanted to assess the impact of
a broad range of doses of caffeine (2.5–20.0 mg/kg) on highly
palatable food intake in mice. Because anxiety has been shown
to suppress appetite, we compared the impact of caffeine on
food intake under habitual conditions vs. anxiogenic conditions.
Since caffeine invigorates behavior, we also studied intake of
palatable food when effort was a component of the decision-
making process, such that food restricted mice could gain access
to higher quantities of food by exertion of effort. In addition,
we also evaluated the ability of caffeine to reverse the effects of
a DA-depleting agent that reduces willingness to work for food
(anergia). We also assessed if this DA-depleting agent changes,
by itself, food intake under habitual, anxiogenic or effortful
conditions. These results could clarify the potential therapeutic
effects of caffeine on appetite under normal or pathological
conditions.
MATERIALS AND METHODS
Subjects
CD1 male mice (24–28 g) purchased from Janvier, France S.A.
were 4 weeks old upon arrival to the laboratory (N = 47),
and after a week of adaptation to the colony conditions, all
experiments started.Mice were housed in groups of three animals
per cage with tap water and standard chow food available ad
libitum in the home cage across the entire experiment, except
in experiments 5–7, in which mice were food-restricted in their
home cage (to a maximum of 85% free feeding body weight)
throughout the study. These animals received between 7 and
8 g of standard chow food per cage during the week days and
between 13 and 14 g during the weekend days to allow normal
growth. The colony was kept at a temperature of 22 ± 2◦C with
lights on from 08:00 to 20:00 h. All animals were covered by
a protocol approved by the Institutional Animal Care and Use
committee of Universitat Jaume I. All experimental procedures
complied with directive 2010/63/EU of the European Parliament
and of the Council, and with the “Guidelines for the Care and Use
of Mammals in Neuroscience and Behavioral Research,” National
Research Council 2003, USA. All efforts were made to minimize
animal suffering, and to reduce the number of animals used.
Pharmacological Agents
Caffeine (1,3,7-trimethylxanthine; Sigma-Aldrich, Spain) was
dissolved in 0.9% w/v saline and was administered 30min before
testing. Saline solution was used as its vehicle control. The range
of caffeine doses (2.5, 5.0, 10.0, and 20.0 mg/kg) was selected
based on previous and pilot studies (27). Tetrabenazine (TBZ)
[(R,R)-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-
pyrido[2,1-a]isoquinolin-2-one] (CIMYT Quimica SL, Spain),
administered 120min before testing, was dissolved in a vehicle
solution of 0.9% saline (80%) and dimethylsulfoxide (DMSO;
20%) (pH = 4.5). DMSO was used as vehicle control. All
solutions were administered intraperitoneally (IP).
Apparatus and Testing Procedures
The same type of food was used in all the experiments; 45mg
(experiments 1–4) or 20mg (experiments 5–7) precision pellets
for rodents (TestDietTM) with a balanced nutrient composition
and a 50% sucrose content that gave it palatable characteristics.
Palatable Food Consumption Under Habitual
Conditions: Continuous or Intermittent Access
During 4 weeks (5 days per week) non-food restricted mice
were placed individually in standard home cages where they
had ad libitum access to highly palatable pellets (45mg each).
Baseline sessions lasted 60min (data were registered every
30min), starting 3 h prior the beginning of the dark cycle.
Thus, animals consumed food in a familiar and repetitive
condition. During 2 more weeks, animals were habituated to
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receive an IP vehicle injection once a week, and sessions
lasted 30min (see Figure 1). Because it has been suggested
that non-continuous access to food increases food consumption
leading to binge eating, we had two conditions of food in
a familiar context: the continuous group had sessions 5 days
per week (Monday to Friday), and the intermittent access
group had sessions 3 days per week (Monday, Wednesday
and Friday). The test phase lasted five more weeks during
which each subject received all doses of caffeine (Experiments
1 and 2) or TBZ (Experiments 3 and 4) in a randomly varied
order, once a week. Body weight was registered 3 times per
week.
Palatable Food Consumption Under Anxiogenic
Conditions
After completing the habitual food-consumption experiments,
the same mice had access to the highly palatable food for three
additional weeks of baseline with no treatment, and shorter
sessions (15min) (see Figure 1). Then, mice in the continuous
and in the intermittent conditions were divided in two treatment
groups: saline or 20mg/kg of caffeine (Experiment 2), andDMSO
or TBZ (8 mg/kg; Experiment 4). Animals that had received
caffeine in the previous experiment also received caffeine in
the present one, and the same was true for animals that had
received TBZ. Doses were selected based on their impact in the
previous experiments. In one single test day, animals were placed
for 15min in a dark and light (DL) paradigm. In the DL box,
one chamber was enclosed and dark, and the open chamber
where the food dish was placed, was intensely illuminated. Tests
started when each subject was placed in the dark chamber. Since
there were no differences in food intake in the DL between
animals in the intermittent and the continuous groups data
from both groups were pooled in order to increase the number
of animals per group. The amount of food (mg) consumed
during 15min was recorded, as well as the time spent in the lit
compartment.
Effort-Based Decision-Making for Palatable Food in a
T-Maze With Barrier
In the last group of experiments (5–7), we studied the impact of
caffeine or TBZ in the T-maze procedure that imposes an effort
restriction in order to get access to higher quantities of food. In
order to make animals to learn and perform the task, mice were
food restricted in their home cage. This procedure is based on
previous published work (26). The T-maze apparatus consisted
of a central corridor with two opposed arms (see Figure 4). Each
arm provided a different density of food: 2 pellets (20mg each)
in the high density (HD) arm, and 1 pellet (20mg) in the low
density (LD) arm. Pellets were located in dishes placed near the
far walls of the maze arms. The HD arm contained a vertical
barrier (12 cm high) that provided the effort-related challenge.
Half the mice had the HD arm with the barrier consistently
located on the left side, while half the mice had the HD arm
and barrier on the right side. During the first training phase
no barrier was present, and for the first 2 days of the initial
training, mice had free access to both arms of the T-maze upon
exiting the start arm, and were allowed to consume all pellets
in both HD and LD arms of the maze before being returned
to the start arm. Upon completion of this initial training, mice
were only allowed to choose one arm of the maze; after the
initial arm choice, the other arm was blocked. During 2 weeks
mice choose between the two arms with no barrier in place.
In the second training phase, a small barrier (6 cm high) was
introduced in the HD arm for 1 week. Animals were then
trained with the 12 cm barrier in the HD arm for the rest of
the sessions. A training phase of 3 weeks was allowed before the
drugs were administered. The test phase started at that moment:
in experiments 5 and 6 animals received a single injection per
week of caffeine (10 mg/kg) or saline vehicle, and of TBZ (4.0
mg/kg) or DMSO vehicle. These lower doses were chosen based
on previous published data from our laboratory (27, 28) on the
impact of caffeine and TBZ on running wheel activity, an activity
that is highly reinforcing and requires a lot of vigor. Thus, TBZ
4.0 mg/kg and caffeine 10 mg/kg did not reduced running, but
TBZ 8 mg/kg did (28). In addition, a pilot study demonstrated
that caffeine (20.0 mg/kg) also reduced running wheel activity
(t-test for independent samples [t(9) = 6.83; p < 0.01], Saline =
1,982.3 ± 128.1, Caffeine 20.0 mg/kg = 1,309 ± 116.5). Based
on these results, for experiments 5–7 we used lower doses of
both drugs. In experiment 7 a different group of animals followed
the same protocol and the pharmacological interactions between
caffeine and TBZ were studied.
Data Analyses
All experiments but 2 and 4 used a within-groups design.
Normally distributed and homogenous data form experiments
1 (A and B), 3 (A and B), and 7 were evaluated by repeated
measures analysis of variance (ANOVA). Further analyses were
conducted by non-orthogonal planned comparisons using the
overall error term to assess differences between each dose and the
control condition (29) (the number of comparisons was restricted
to the number of treatments minus one). T-tests for dependent
samples analysis were used for experiments 5 and 6. Experiments
2 and 4 used a between groups design and data were analyzed
by t-tests for independent samples. Additionally, comparison
of body weight progression was analyzed independently with
repeatedmeasures ANOVA for every group of animals in all these
experiments, plus one-way ANOVAs were used to compare body
weight between groups under different food access conditions
(experiment 8). All data were expressed as mean ± SEM, and
significance was set at p < 0.05. STATISTICA 7 software was
used.
RESULTS
Experiments 1 A and B. Effect of Caffeine
on Highly Palatable Food Intake Under
Habitual Conditions: Continuous or
Intermittent Access
The effect of caffeine (0, 2.5, 5.0, 10.0, and 20.0 mg/kg) on pellet
intake was recorded during 30min sessions. Repeated measures
ANOVA for continuous access (N = 8) revealed a significant
effect of caffeine [F(4, 28) = 5.91; p < 0.01]. Planned comparisons
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FIGURE 1 | Schematic representation of the cage for habitual and limited food access, and the DL apparatus used in experiments 1–4, with the experimental
procedure.
FIGURE 2 | Effect of saline or caffeine (2.5, 5.0, 10.0, and 20.0 mg/kg) on palatable food intake in a familiar context under continuous access (A) or under intermittent
access (B), and effect of saline or caffeine (20.0 mg/kg) on food intake evaluated on a DL box (C). Mean ± S.E.M. milligrams consumed. **p < 0.01 significantly
different from vehicle.
showed that the highest dose of caffeine (20.0mg/kg) significantly
increased the amount of palatable food consumed (p < 0.01;
Figure 2A). The repeated measures ANOVA for the intermittent
access group (N = 8) revealed also a significant effect [F(4, 28)
= 4.77; p < 0.05], and the planned comparisons also confirmed
that the highest dose of caffeine increased the amount of pellets
consumed (p < 0.01; Figure 2B).
Experiment 2. Effect of Caffeine on Highly
Palatable Food Intake Under Anxiogenic
Conditions
The same mice used in the previous experiments were
used in order to evaluate the effect of caffeine on pellet
consumption under anxiogenic conditions. Because continuous
and intermittent access exposition did not differ in the DL
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FIGURE 3 | Effect of DMSO or TBZ (1, 2, 4, and 8 mg/kg) on palatable food intake in a familiar context under continuous access (A) or under intermittent access (B),
and effect of DMSO or TBZ (8 mg/kg) on food intake evaluated on a DL box (C). Mean ± S.E.M. milligrams consumed.
paradigm data from both groups were pulled to increase the
number of animals (N = 16). Mice were split into two groups;
one group received the dose of caffeine that had increased intake
(20.0 mg/kg) in experiment 1 and the other group received saline.
The t-test for independent samples revealed that this dose of
caffeine significantly decreased food intake (mg in 15min) in the
DL paradigm [t(16) = 2.90, p < 0.01; Figure 2C]. However, this
dose of caffeine was not high enough to induce anxiety assessed
with classical measures, such as time spent in the lit compartment
[t(16) = 0.098; n.s]. The saline group spent 118.4 ± 14.3, and the
caffeine group spent 120.0± 8.6 s.
Experiments 3 A and B. Effect of TBZ on
Highly Palatable Food Intake Under
Habitual Conditions: Continuous or
Intermittent Access
The effect of TBZ (0, 1.0, 2.0, 4.0, and 8.0 mg/kg) on pellet
intake was evaluated during 30min sessions. Repeated measures
ANOVA for continuous access (N = 7) did not show a significant
effect of TBZ [F(4, 24) = 0.51; n.s.] on amount of food consumed
(Figure 3A). The repeatedmeasures ANOVA for the intermittent
access group (N = 7) revealed no significant effect either [F(4, 24)
= 1.34; n.s.; Figure 3B].
Experiment 4. Effect of TBZ on Highly
Palatable Food Intake Under Anxiogenic
Conditions
Mice used in experiments 3 A and B were used to evaluate the
effect of TBZ on food intake in the DL box (Figure 3C). These
animals (N = 14) from the continuous and intermittent groups
were equally distributed into two treatment groups: DMSO
vehicle or TBZ (8.0 mg/kg). The t-test for independent samples
revealed no significant differences on total food intake between
these two groups [t(12)= 0.55; n.s.]. Classical measures of anxiety,
such as time in the lit compartment, showed no significant effect
of TBZ either [t(12) = 0.54; n.s.]. The DMSO group spent 171.3
± 16.8 s in the lit compartment, and TBZ group spent 184.4 ±
17.5 s.
Experiments 5 and 6. Effect of Caffeine or
TBZ on Seeking of Highly Palatable Food
Under Effortful Conditions
A new group of mice (N = 9) was trained in the T-maze.
During the testing phase, some animals received caffeine (10.0
mg/kg) or its vehicle in the 2 first weeks and then TBZ
(4.0 mg/kg) or its vehicle in the last 2 weeks and another
group of animals received drugs in the reversed order. In
addition, vehicle or drug treatments were administered in a
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FIGURE 4 | Schematic representation of the T-maze apparatus used in the
present studies, and experimental procedure. All the surfaces and the
doorway were constructed out of Plexiglas, and the barrier (depicted in the
high-density arm, to the left) was constructed of wire mesh. The high density
(HD) arm contained two food pellets, and the low density (LD) arm contained
one food pellet.
randomized order. This experiment was also a pilot for the
following study. The t-test for dependent samples showed that
caffeine did not modify amount of food consumed [t(8) =
0.38; n.s.] or selection of effortful options (HD arm) [t(8)
= 0.43; n.s.] to get it, although it reduced latency to reach
the food across all the trials [t(6) = 3.21; p < 0.01]. In
contrast, 4.0 mg/kg TBZ did significantly reduced quantity of
food consumed [t(8) = 3.44; p < 0.01] because it reduced
the number of HD arm choices [t(8) = 3.92; p < 0.01].
However, there was no significant effect on latency to reach
the food across trials [t(7) = −1.71; n.s.]. Data can be seen in
Figures 5A–F.
Experiment 7. Caffeine Reversal of TBZ
Effects on Seeking of Highly Palatable
Food Under Effortful Conditions
Naïve mice (N = 8) received DMSO or TBZ (4.0 mg/kg)
120min before test and saline or caffeine (2.5 or 5.0 mg/kg)
30min before test (Figures 6A–C). Repeated measures ANOVA
yielded an overall effect of drug treatment [F(3, 21) = 11.91, p
< 0.01] on HD arm selection. Planned comparisons showed
that TBZ/VEH and TBZ/Caffeine 2.5 mg/kg condition were
significantly different from VEH/VEH control condition (p
< 0.01). In addition, co-administration of TBZ with the
highest dose of caffeine (5.0 mg/kg) significantly increased
HD arm selection (p < 0.01) compared to the TBZ/VEH
condition, indicating an attenuation of the DA-depleting agent
effects. LD arm selection was also modified in the reversal
study. Repeated measures ANOVA indicated a significant
effect of drug treatment [F(3, 21) = 8.44, p < 0.01]. Planned
comparisons showed that the TBZ/VEH and TBZ/Caffeine 2.5
mg/kg condition were significantly different from VEH/VEH
control condition (p < 0.01), and TBZ plus caffeine (5.0
mg/kg) significantly decreased LD arm selection compared
to TBZ/VEH condition (p < 0.01). The same pattern of
results was found for the dependent variable mg of pellets
consumed during the T-maze performance: a significant effect
of drug treatment [F(3, 21) = 4.15, p < 0.01], and a significant
difference between VEH/VEH and TBZ/VEH (p < 0.01) on
the one hand, as well as with TBZ/Caffeine 2.5 mg/kg on
the other (p < 0.05). Moreover, TBZ/Caffeine (5.0 mg/kg)
significantly restored mg consumed compared to TBZ/VEH
condition (p < 0.01).
Experiment 8. Body Weight Progression
Under Different Food Access Conditions
Body weight progression from week 1 till week 11 from
animals in experiments 1A-B, and 7 as well as a control group
under standard house food conditions are shown in Figure 7.
Independent repeated measures ANOVAs for body weight data,
showed that the four groups of animals had a statistically
significant progression in their body weight gain: standard
control [F(10, 140) = 18.15, p < 0.01], continuous access [F(10, 140)
= 91.55, p < 0.01], intermittent access [F(10, 140) = 167.81,
p< 0.01] and restricted access in the T-maze experiment [F(10, 80)
= 22.52, p < 0.01]. Planned comparisons indicate that animals
in the standard group, in the continuous group (Experiments
1A + 3A), and in the intermittent group (Experiments 1B +
3B) increased body weight every week (p < 0.01). However,
because of the home food restriction regime, animals in the
restricted access condition (experiment 7), reduced significantly
their initial body weight (<15%) during the 5 first weeks, but
by week 7, in spite of the food restriction, they had returned
to their initial body weight, and progressively increased every
week (p < 0.01) after that. Further comparisons using a between
groups ANOVA for the average weight during weeks 2–6, or
weeks 7–11, demonstrated that from week 2–6 there was a
significant effect of type of food access on body weight [F(3, 50)
= 20.9, p < 0.01], and the planned comparisons showed that
only the food restricted group in the T-maze experiment was
significantly different from the standard group (p < 0.01). The
one-way ANOVA for the average weight in weeks 7–11 also
showed a significant effect [F(3, 50) = 18.0, p < 0.01], but in
this case, all groups were statistically different from the standard
group (p < 0.05 for the continuous group, and p < 0.01 for the
other two groups).
DISCUSSION
The present experiments indicate that the non-selective
adenosine antagonist caffeine produces a complex pattern of
effects on sweet food consumption depending on the conditions
in which the food is presented to mice. In experiment 1 and
3 we have used two procedures of food access, in which after
several weeks of daily or intermittent access to palatable food
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FIGURE 5 | Impact of caffeine (vehicle or 10 mg/kg; A–C) or TBZ (vehicle or 4 mg/kg; D–F) on latency to food across 30 trials (A,D), HD arm selection (B,E), and total
food consumed (C,F) in the T-maze with barrier. Mean (±S.E.M.) seconds from gate to food, number of arm choices in 30 trials and mg of food consumed. **p < 0.01
significantly different from their corresponding vehicle.
FIGURE 6 | Effects of saline or caffeine (2.5 and 5.0 mg/kg) in mice co-administered with DMSO or TBZ (4 mg/kg) on HD (A), LD (B) arm selection, and total food
consumed (C) in the T-maze with barrier. Mean (±S.E.M.) number of arm choices in 30 trials and mg of pellets consumed. *p < 0.05; **p < 0.01 significantly different
from VEH/VEH; ##p < 0.01 significantly different from TBZ/VEH.
that is different from the standard chow, mice show high levels
of consumption. There were no differences in food consumed
or in body weight gain between the two access conditions.
Considering that these animals are non-food restricted, an intake
of around 600mg of food in half an hour is remarkable. These
results suggest that our procedures could have induced “binge
Frontiers in Psychiatry | www.frontiersin.org 7 September 2018 | Volume 9 | Article 411
Correa et al. Caffeine and Food Consumption
FIGURE 7 | Body weight progression across different groups of mice exposed to different food access conditions. (A) Body weight (gr) gain from week 1 till week 11,
and (B) average body weight of the four groups during two periods of 5 weeks each. Mean (±S.E.M.) weight in grams. *p < 0.05; **p < 0.01 significantly different
from standard group.
eating,” which is characterized by excessive food intake during
a short period of time, and typically is induced by offering
a highly palatable food or fluid on a limited, or intermittent
schedule (30–32). In addition, the higher dose of caffeine used
(20.0 mg/kg) increased consumption of this palatable food to
around 1,100 milligrams (25 pellets, 45 mg each) under both
access conditions. The effect of caffeine is in agreement with a
recent study in which acute caffeine (up to 26 mg/kg) increased
standard chow consumption under habitual home conditions
on the first 2 h (10). In that study, animals did not reach such
a high level of intake (the maximum consumption of chow
was 400mg in 2 h). Thus, caffeine under repeated but limited
access conditions, did not have an anorectic effect, but instead it
potentiated patterns of binge eating for palatable food.
Because caffeine can have anxiogenic effects as well (27, 33),
and anxiety and stress can affect food consumption, we explored
the impact of the highest dose of caffeine (20.0 mg/kg) that
was effective in increasing food intake, to evaluate its effects
under anxiogenic conditions such as the bright open area of the
classical DL box. Comparing animals that had received saline
with those that had received the 20.0 mg/kg dose of caffeine, we
observed an effect that was opposite to that seen in the previous
experiment; caffeine decreased the amount of food consumed in
15min. However, this dose of caffeine did not modify classical
anxiety measures. This lack of anxiety effects is in accordance
with previous experiments in mice using similar doses (10, 27).
Thus, although caffeine at this dose did not show signs of being
anxiogenic in terms of exploration in the DL box, it did reduce
food consumption, showing that this variable is possibly more
sensitive to the anxiogenic properties of caffeine.
The patterns of results observed after caffeine administration
were not observed after a broad range of TBZ doses that
had previously been demonstrated to reduce DA in ventral
striatum of mice (28) and, more specifically, in Nacb core of
rats (34). TBZ depletes DA in the central nervous system by
reversibly inhibiting the vesicle monoamine transporter type 2
and preventing monoamine uptake into presynaptic neurons
(35). Thus, in the present results, DA depletion did not affect
consumption of food with a high content of sucrose, neither in a
familiar context nor in an anxiogenic one when there is no work
or effort involved in the access to the food.
As a psychostimulant, caffeine can also affect locomotion and
exploration. Increases in locomotion with moderate doses of
caffeine are seen in studies were a low baseline activity is seen,
such as mice habituated to an open field (27, 33). However,
in situations of high baseline levels such as voluntary running,
high levels of locomotion are easier to decrease (27). Thus, for
the following T-maze effort conditions in which exploration,
voluntary running and barrier climbing are required, lower
doses of caffeine were used. It has been demonstrated that
the T-maze is a good tool to measure effort-related decision-
making in rodents (26, 36, 37), and that this paradigm is
sensitive to behavioral manipulations such as pre-feeding, which
devalues food reinforcement by reducing appetite and food
motivation increasing omissions (26). As seen in the present
results (Figures 5A–C) caffeine (10.0 mg/kg) decreased latency
to reach the food independently of the presence or absence of
the barrier. However, this dose did not affect preference for the
arm that contained more pellets and did not increase omissions
(data not shown), which resulted in no changes in pellets earned
and consumed. The pattern of results was quite different when
anergia was induced by administering the DA-depleting agent
TBZ. At this dose, TBZ did not have a significant effect on latency
to reach the food, although some animals did show increased
latency. TBZ-treated animals reduced selection of the HD arm
but compensated by increasing the selection of the LD arm (see
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Figure 6B). This treatment did not change appetite since animals
did not increase the number of omissions and eat all the pellets
that they earned, although they were significantly fewer (see
Figures 6F, 7C). Interestingly, co-administration of a relative low
dose of caffeine (5.0 mg/kg), reversed this anergia inducing effect
of TBZ. This reversal of TBZ effects by caffeine is probably due
to adenosine-DA receptor interaction having opposite effects on
the adenylyl cyclase-related signal transduction cascade. Thus,
caffeine acting on A1 receptors would reduce the impact of
D1 receptors located in the substance P containing neurons
of Nacb, and the same would be true for caffeine acting on
the A2A receptor co-localized with D2 receptors in enkephaline
containing neurons (21–23).
In operant paradigms that require low effort (variable or
fixed intervals schedules) high doses of caffeine (≥ 50.0 mg/kg),
reduce lever pressing for chow pellets (11), but doses up to
20.0 mg/kg increased lever pressing although there was no net
increase in access to highly palatable food (12). In operant
schedules that require high effort (fixed ratio 20 or progressive
ratio schedules), doses up to 40.0 mg/kg of caffeine reduced lever
pressing for palatable food (12), and in contrast, caffeine (up to
25.0 mg/kg) improves performance in animals responding for
sucrose solutions (13, 14, 38).
In summary, caffeine administered acutely to mice at
moderate to high doses (27) can potentiate binge eating when
subjects have already stablished a pattern of excessive eating.
However, this same dose led to clear reductions in food
consumption if the context is prone to increase anxiety levels
(i.e., the DL box). Although lower doses of caffeine do not
change appetite and do not impair orientation toward food under
effortful conditions, they help to approach the food by improving
speed and by reversing performance to normal levels when
anergia/ psychomotor retardation was induced by DA-depletion.
This pattern of results was quite different for TBZ.
Although TBZ shifted choice behavior in the T-maze, the food
consumption studies showed that TBZ had no effect on food
intake. Thus, TBZ-induced shifts in effort-related choice do not
appear to be due to changes in primary food motivation, the
unconditioned reinforcing properties of food, or food preference.
These data support previous results indicating that Nacb DA
depletions and TBZ do not substantially impair appetite for
food, or produce a general disruption of all aspects of primary
food motivation (34, 39–41). Nacb DA depletions did not reduce
food intake or feeding rate, nor did they impair food handling
(40). However, depletion of mesolimbic DA has been reported
to produce impairments in behavioral activation, and, more
specifically, in effort-related aspects of food motivation (16). The
shift in choice induced by DA depletion or antagonism in animals
tested in the T-maze barrier task has been demonstrated to be a
valid rodent model of psychomotor slowing, fatigue and anergia
(24, 26, 36, 37, 42–45). After DA depletions animals shift their
behavior toward the lower effort options, however, they are still
oriented toward the food. Moreover, previous work has also
demonstrated that, if animals do not have an option because
both arms have a barrier or because there is no food in the no-
barrier arm, animals perform at control levels, demonstrating
that DA depletion or antagonism does not block the absolute
motor capacity of the animal to climb the barrier, and does not
reduce general food motivation (24, 26, 37, 42).
A DA system that also has been implicated in food
motivation is the innervation of the lateral hypothalamus (LH).
LH DA sources include local hypothalamic monoaminergic
neurons expressing enzymes for DA synthesis (46), as well
as ascending projections from the Ventral Tegmental Area
(VTA) (47). It has been suggested that DA release in the LH
regulates the consummatory component of feeding behavior
(48). Thus, DA increases during feeding in proportion to
meal size (49), and to the appearance of satiation processes
(48, 50). Furthermore, low sucrose intake was associated with
increased VTA DA (51), and DA administration into the
LH produced anorectic effects (52, 53). However, although
we cannot completely discount the idea that TBZ could be
having an impact on LH neurons, the lack of results on food
consumption after TBZ administration in experiments 3A-
C, when mice had direct access to the food, and the clear
impact of TBZ in experiments 6 and 7 when an effortful
approach is essential to get access to food, indicates that our
experimental conditions are more related to Nacb DA than
LH DA. Moreover, because the hypothalamus in rodents seems
sparse in adenosine receptors (54, 55), it does not seem likely that
caffeine could be acting on LH neurons to modulate palatable
food intake.
The present work has potential clinical relevance, since
appetite is impaired in many disorders such as anorexia
and bulimia, anxiety and depression. In addition, effort-
related motivational symptoms such as anergia, fatigue,
and psychomotor slowing seen in depressed humans are
very resistant to classical antidepressant treatments such
as 5-HT uptake inhibitors (56, 57), and caffeine has been
demonstrated to enhance the antidepressant-like activity of
common antidepressant drugs (58). Moreover, caffeine is
an antagonist at both A1 and A2A adenosine receptors, and
evidence indicates that selective A2A receptor antagonists
may be useful as treatments for motivational deficits seen in
depression and other disorders (16, 36). Further research on the
motivational effects of adenosine antagonists may contribute to
a greater understanding of the neural mechanisms mediating
various aspects of motivation.
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